ANZUP ANNUAL SCIENTIFIC MEETING
ABSTRACTS
bs_bs_banner
List of Best of the Best Oral Abstracts
19
List of Best of the Best Oral Abstracts These people are being considered for Best of the Best Awards. Please refer to page 6 for the full listing of awards.
Renal/Bladder/Testis Monday 13 July, 11:00am–1:00pm Ross Calopedos Patterns and outcomes of care for bladder cancer in New South Wales: A population-wide study of linked data abs#13
Best of the Best Orals Monday 13 July 2014, 3:30pm–4:30pm Prunella Blinman Patients’ preferences for adjuvant sorafenib after resection of intermediate or high risk renal cell carcinoma in the SORCE trial: what makes it worthwhile? abs#14 Ross Calopedos The Australian Laparoscopic Non Robotic Radical Prostatectomy Experience – Analysis of 2943 Cases abs#15 Sean Huang Correlation between multiparametric MRI findings and radical prostatectomy specimens abs#16 Shankar Siva Tolerability of Stereotactic Ablative Body Radiotherapy (SABR) for primary renal cell carcinoma: preliminary analysis of the FASTRACK clinical trial abs#17 Allan Smith e-TC: Development and pilot testing of an online psychological intervention for testicular cancer survivors abs#18 Jane Ussher Sexual Wellbeing and Quality of Life after Prostate Cancer: A comparison of Gay/ Bisexual Men and Heterosexual Men abs#19
Redefining Medicine/Alternate Trial Design Tuesday 14 July, 10:30am–12:00pm Shahneen Sandhu Antitumour Activity of the Poly (ADP-ribose) Polymerase (PARP) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (CRPC) in the TOPARP trial abs#20
ABSTRACTS
bs_bs_banner
List of Best of the Best Oral Abstracts
19
List of Best of the Best Oral Abstracts These people are being considered for Best of the Best Awards. Please refer to page 6 for the full listing of awards.
Renal/Bladder/Testis Monday 13 July, 11:00am–1:00pm Ross Calopedos Patterns and outcomes of care for bladder cancer in New South Wales: A population-wide study of linked data abs#13
Best of the Best Orals Monday 13 July 2014, 3:30pm–4:30pm Prunella Blinman Patients’ preferences for adjuvant sorafenib after resection of intermediate or high risk renal cell carcinoma in the SORCE trial: what makes it worthwhile? abs#14 Ross Calopedos The Australian Laparoscopic Non Robotic Radical Prostatectomy Experience – Analysis of 2943 Cases abs#15 Sean Huang Correlation between multiparametric MRI findings and radical prostatectomy specimens abs#16 Shankar Siva Tolerability of Stereotactic Ablative Body Radiotherapy (SABR) for primary renal cell carcinoma: preliminary analysis of the FASTRACK clinical trial abs#17 Allan Smith e-TC: Development and pilot testing of an online psychological intervention for testicular cancer survivors abs#18 Jane Ussher Sexual Wellbeing and Quality of Life after Prostate Cancer: A comparison of Gay/ Bisexual Men and Heterosexual Men abs#19
Redefining Medicine/Alternate Trial Design Tuesday 14 July, 10:30am–12:00pm Shahneen Sandhu Antitumour Activity of the Poly (ADP-ribose) Polymerase (PARP) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (CRPC) in the TOPARP trial abs#20
